BioTech Medics Inc (BMCS)

[energy_wave]

NOTE 4 – STOCKHOLDERS’ EQUITY

The Company has authorized an unlimited number of shares at a $0.001 par value shares of common stock, and 205,356,178 common
shares issued and outstanding as of March 31, 2025. During the period ended March 31, 2025, the Company did not issue Series A
preferred shares to certain shareholders for cash to be used as working capital. Collectively as of March 31, 2025 the Company has
79,775 total digital currencies who’s value at this date was approximately $70 million based upon the Sumcoin closing price on
December 31, 2021 of $979.04 per coin. As of the date of this filing the Sumcoin value has risen to approximately $1,398.36. Note: the
coin’s value changes every 20 minutes. Because of the uncertain value of this currency and lack of liquidity (trading only pier-to-pier)
Management will seek to liquidate this currency in 2024-2025 and procure other commodities like our calcium assets. There are 10
million authorized preferred shares (par value .001) including 5 million Series A, and 5 million Series B shares. Management has the
authority to set the rights powers and privileges to these shares.

https://www.otcmarkets.com/file/company/financial-report/470903/content